Up to Date News

Independent statistical studies and assessments
 

Exciting New Research in Autoimmune Diseases

The World's First Fully Clinically Documented Successful Clinical Recoveries From Autoimmune Chron's Disease

Chron's disease Protocol
Ulcerative colitis Protocol
Systemic Lupus Erythematosus (SLE) Protocol
 

Patients' own Reports - New Recovered patient's reports continually being added.
 

Canadian Pilot Study
 

Washington Medical School Research
 

London: St George Hospital Research
 

The CFIDS Protocol Contacts in various countries
 

Independent medical professionals' comments'
 

UK CFIDS Health Web Site
 

Dr Nash Petrovic MD in World Media
 

Dr Nash Petrovic MD in World Media: BBC Panorama programme
 

German National Encyclopedia Entry - Dr. Nash Petrovic MD, Global Leader in the CFIDS Field
 

USA Federal and Drug Administration (FDA) Petrovic CFIDS Health Centre Registration Compliance 2019 (2008-2019)
 

Famous and Prominent International Clients and Celebrities
 

 

CFIDS Protocol contacts in Australia

Mr. Jason White  
E-mail contact: oneonone23@hotmail.com
Tel : 03 533 41292
   
 

CFIDS Protocol contacts in the United Kingdom

Featuring of Dr Petrovic's successfully recovered patient on BBC Panorama programme

All prospective UK patients are advised to contact:

Mr.Gary Winn (architect)  
E-mail contact: gary@progressionarchitects.com or thedairy@globalnet.co.uk
Contact Tel / Fax : +44 01564 730 191
Website: www.progressionarchitects.com
   

CFIDS Protocol contacts in the USA

Mrs. Char Gilchrist
Chemical dependency counsellor and Marketing Director of New Beginnings on:
E-mail contact: chargilcrist@gmail.com
Contact Tel: 612-418-1427
   
Ms. Sandra Silliman
New York based non practising clinician who has been closely involved with various USA National Research Foundation Programmes on CFIDS on:
E-mail contact: sansillman@gmail.com and pittiechick59@gmail.com
Contact Tel: 605 622 5069
   


Consent for Publication of Contact Details

All contact details listed on this page are published with the explicit, informed consent of the individuals involved. Each patient was fully informed about what information would be displayed, its public accessibility, and the purpose of publication.
Consent for publication has been obtained in writing and is securely retained in our private records. Patients retain the right to withdraw their consent at any time, and any requests for removal will be promptly actioned.
We adhere to ethical and legal guidelines to ensure patient privacy and uphold transparency and trust in all communications.